$8.820
-0.186 (-2.11%)收盘时
VMD 资讯
VMD 事件
Viemed Healthcare Authorizes Share Repurchase Program Through March 2027
Viemed Healthcare has authorized a share repurchase program effective through March 2027. Under the share repurchase program, which constitutes a normal course issuer bid under applicable Canadian securities laws, Viemed may purchase up to 1,930,131 common shares of the company from time to time, representing approximately 5% of the total issued and outstanding common shares as of March 4. Daily purchases will be limited to 25% of the average daily volume for the four calendar weeks preceding the date of purchase. The company may discontinue its purchases at any time, subject to compliance with applicable securities laws. The common shares purchased by the company will be cancelled.
Viemed Healthcare completes acquisition of Lehan's Medical Equipment
Viemed Healthcare has completed the previously disclosed acquisition of Illinois-based Lehan's Medical Equipment for a base purchase price of $26M, subject to customary adjustments, plus estimated contingent payments of $2.2M. In 2024, Lehan generated net revenues of approximately $25.7M and Adjusted EBITDA of approximately $7.4M. Viemed funded the acquisition through a combination of cash on hand and borrowings from its existing credit facilities. Viemed anticipates increasing its previously issued full-year 2025 guidance range to account for the expected contribution from this acquisition when it reports earnings results for the quarter ended June 30.
Viemed Healthcare board authorizes share repurchase program up to 5%
Viemed Healthcare Board of Directors has authorized a share repurchase program, effective through June 2026. Under the share repurchase program, Viemed may purchase up to 1,976,441 common shares of the Company from time to time in accordance with applicable securities laws, representing approximately 5% of the total issued and outstanding Common Shares as of March 31, 2025. The Company intends to repurchase Common Shares through open market purchases, block purchases or otherwise in accordance with applicable securities laws. Subject to certain exceptions for block purchases, daily purchases will be limited to 25% of the average daily volume for the four calendar weeks preceding the date of purchase.
Viemed entered into definitive agreement to acquire Lehan's Medical Equipment
Viemed Healthcare announced that it has entered into a definitive agreement to acquire Illinois-based Lehan's Medical Equipment, a healthcare company offering home medical equipment with specialties in respiratory care and women's health. "Operating for nearly 80 years, Lehan has established a well-deserved reputation for its expertise in home medical equipment with a particular emphasis on women's health and a deep commitment to community engagement," said Viemed Chief Executive Officer Casey Hoyt. "Lehan gives us a strong platform to execute our growth strategy in a large and fast-growing market with very familiar products. The acquisition also diversifies our product mix into maternal health that we expect to extend to our existing payer relationships across the country. This is a highly motivated and experienced team that has created tremendous brand equity, and we are pleased to join forces with them."
Viemed Healthcare sees FY25 revenue $254M-$265M, consensus $251.43M
Sees FY25 adjusted EBITDA $54M-$58M.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。